Skip to main content

Advertisement

Log in

Immunoadsorption for the treatment of narcolepsy with cataplexy

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. International Classification of Sleep Disorders (ICSD) (1990) Diagnostic and Coding Diagnostic Classification Steering Committee (Thorpy MJ, chairman). American Sleep Disorders Association. Narcolepsy 347:38–43

    Google Scholar 

  2. Mignot E, Lin L, Rogers W et al (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686–699

    Article  PubMed  CAS  Google Scholar 

  3. Smith AJ, Jackson MW, Neufing P et al (2004) A functional autoantibody in narcolepsy. Lancet 364:2122–2124

    Article  PubMed  CAS  Google Scholar 

  4. Knudsen S, Mikkelsen JD, Jennum P (2007) Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport 18:77–79

    Article  PubMed  Google Scholar 

  5. Billiard M, Bassetti C, Dauvilliers Y et al (2006) EFNS guidelines on management of narcolepsy. Eur J Neurol 13:1035–1048

    Article  PubMed  CAS  Google Scholar 

  6. Hecht M, Lin L, Kushida CA et al (2003) Report of a case of immunosuppression with prednisone in 8-year-old boy with an acute onset of hypocretin deficiency narcolepsy. Sleep 26:809–810

    PubMed  Google Scholar 

  7. Lecendreux M, Maret S, Bassetti C et al (2003) Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 12:347–348

    PubMed  Google Scholar 

  8. Dauvilliers Y, Carlander B, Rivier F et al (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56:905–908

    Article  PubMed  CAS  Google Scholar 

  9. Dauvilliers Y (2006) Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 60:153

    Article  PubMed  Google Scholar 

  10. Chen W, Black J, Call P et al (2005) Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol 58:489–490

    Article  PubMed  Google Scholar 

  11. Fronczek R, Verschuuren J, Lammers GJ (2007) Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol 254:1607–1608

    Article  PubMed  Google Scholar 

  12. Hershko AY, Naparstek Y (2005) Removal of pathogenic autoantibodies by immunoadsorption. Ann NY Acad Sci 1051:635–646

    Article  PubMed  CAS  Google Scholar 

  13. Antozzi C, Frassoni C, Vincent A et al (2005) Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology 64:1290–1293

    PubMed  CAS  Google Scholar 

  14. Terzano MG, Parrino L, Smerieri A et al (2002) Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med 3:187–199

    Article  PubMed  Google Scholar 

  15. Morrish E, King MA, Smith IE et al (2004) Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 5:37–41

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Flavio Villani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pincherle, A., Villani, F., Ferini Strambi, L. et al. Immunoadsorption for the treatment of narcolepsy with cataplexy. Neurol Sci 29, 499–500 (2008). https://doi.org/10.1007/s10072-008-1036-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-008-1036-9

Keywords

Navigation